subject: Osteoarthritis - Pipeline Assessment and Market Forecasts to 2017 [print this page] Osteoarthritis - Pipeline Assessment and Market Forecasts to 2017
Summary
GlobalData, the industry analysis specialist's new report, "Osteoarthritis - Pipeline Assessment and Market Forecasts to 2017" is an essential source of information and analysis on the global osteoarthritis therapeutics market. The report identifies the key trends shaping and driving the global osteoarthritis therapeutics market. The report also provides insight on the competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global osteoarthritis therapeutics market.
Osteoarthritis - Pipeline Assessment and Market Forecasts to 2017
Market Research
Scope
Annualized global osteoarthritis therapeutics market revenues data from 2001 to 2009, forecast forward for 7 years to 2017.
Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. The first-in-class drugs act through new mechanisms of action such as Nuclear Factor-KappaB (NF-kB) activation inhibitors, TNF alpha blockers, cannabinoid receptor (CB2) agonists and protease inibitors.
Analysis of the current and future market competition in the global osteoarthritis therapeutics. Key future market players covered are Pfizer, Novartis AG, J&J and Crystalgenomics.
Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with osteoarthritis therapeutics market.
Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving the global osteoarthritis therapeutics market.
Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global osteoarthritis therapeutics market in future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
What's the next big thing in the global osteoarthritis therapeutics market landscape? Identify, understand and capitalize.
